18 February 2022>: Original Paper
Impact on Waitlist Outcomes from Changes in the Medical Eligibility of Candidates for Simultaneous Liver-Kidney Transplantation Following Implementation of the 2017 Organ Procurement and Transplantation Network/United Network for Organ Sharing Policy in the United States
Shingo Shimada 1ADEF , Toshihiro Kitajima 1BCE , Yukiko Suzuki 1BD , Yasutaka Kuno 1BD , Tayseer Shamaa 1BC , Tommy Ivanics 1BCE , Kelly Collins 1DE , Michael Rizzari 1BD , Atsushi Yoshida 1BD , Marwan Abouljoud 1BD , Dilip Moonka 2BD , Shunji Nagai 1ACE*DOI: 10.12659/AOT.934850
Ann Transplant 2022; 27:e934850
Table 7 Cause of 1-year death in patient who underwent simultaneous liver-kidney transplantation between the eras.
n (%) | Before the 2017 policyn=102 (68.9) | After the 2017 policyn=46 (31.1) | P value |
---|---|---|---|
Graft failure, n (%) | 4 (3.9) | 1 (2.2) | 0.09 |
Infection, n (%) | 37 (36.3) | 15 (32.6) | |
Malignancy, n (%) | 6 (5.9) | 1 (2.2) | |
Cardiovascular disease, n (%) | 23 (22.5) | 6 (13.0) | |
Respiratory failure, n (%) | 3 (2.9) | 5 (10.9) | |
Brain hemorrhage, infarction, n (%) | 8 (7.8) | 1 (2.2) | |
Multi organ failure, n (%) | 7 (6.9) | 8 (17.4) | |
Others, n (%) | 14 (13.7) | 9 (19.6) | |
SLK – simultaneous liver-kidney transplantation. |